The Saturday Standard — Vol. 23Saturday, October 10, 2026 As always, coffee first, fellas — and let's talk about the first drug approved to take the brakes off muscle. The ResearchThe first myostatin drug is here. What does that even mean?What myostatin does. Myostatin is a protein your body makes to limit how much muscle you build. Think of it as a brake. We know what happens when the brake fails. In 2004, doctors in Germany described a boy born with two broken copies of the myostatin gene. He had visibly oversized muscles from birth, and at four and a half he could hold two 3-kilogram dumbbells straight out at arm's length.¹ That has made myostatin one of the most chased targets in muscle medicine. What got approved. On September 11, the FDA approved Isembyld (apitegromab) from Scholar Rock. It is an antibody that keeps myostatin from switching on, given by IV infusion every four weeks.² It is approved for one disease: spinal muscular atrophy, or SMA, a genetic condition that destroys the nerves that control movement. Patients must be 2 or older and already on a drug that targets the underlying gene.² For SMA families, this matters. Every SMA drug before it went after the nerve. This is the first one aimed at the muscle.² The honest caveats. The benefit is real but modest. The pivotal trial treated 188 patients aged 2 to 21 for a year.²·³ Children on the approved dose improved by 2.2 points on a 66-point motor function scale compared with placebo. About a third of them gained at least 3 points, versus about 1 in 7 on placebo.² Fractures occurred in 9% of patients on the approved dose versus 2% on placebo, and the label warns they can happen without a fall.² It also took two tries. The FDA turned the drug down in September 2025 over problems at a third-party manufacturing plant, not over the drug's safety or effectiveness.⁴ Why you're hearing about it. The bigger market is not muscular diseases. It is GLP-1 drugs. People on semaglutide and tirzepatide lose muscle along with fat, and drug companies want to sell the fix. Two trials show where this is heading. In Lilly's BELIEVE trial, 507 adults with obesity got semaglutide, bimagrumab (an antibody that blocks the receptor myostatin acts through), or both. On semaglutide alone, about 72% of the weight lost was fat. With bimagrumab added, almost 93% was.⁵ In Regeneron's COURAGE trial, people on semaglutide alone lost 6.6% of their lean mass in 26 weeks. Adding trevogrumab, a myostatin antibody, cut that roughly in half.⁶ A third combination that also blocked a second muscle-limiting protein preserved even more. It also brought more serious side effects, muscle spasms in 41% of patients, and both of the trial's deaths. No link to the drug was found in either death.⁶ Keeping lean mass on a scan is not the same as keeping strength. COURAGE reported no strength results, and the authors say whether the preserved muscle translates into function "requires further investigation."⁶ Where this could go. I think this is going to change the way we look at muscle growth. For as long as men have lifted, your genes have put a brake on how much muscle you can build. Myostatin is one of the biggest pieces of that brake, and now there is an approved drug that releases it. Releasing the brake has not meant unlimited growth, at least not yet. On its own, bimagrumab added about 2.5% to lean mass in the BELIEVE trial.⁵ That is real, but it is not the boy in Germany. Right now these are IV infusions given in a clinic. At some point, some version will likely come as a pill or a shot for a broad swath of people. It is too early to know when, or what that will look like. What about the gym? None of these drugs is approved for healthy men. Isembyld's label covers SMA and nothing else.² The products sold online as myostatin blockers, like follistatin, are unregulated and banned by the World Anti-Doping Agency, and Poison Control tells people not to use them.⁷ One case series described 11 bodybuilders who developed fluid buildup behind the retina after injecting high-dose follistatin.⁷ Blocking this pathway touches more than muscle. An earlier experimental drug, ACE-031, was stopped in a trial of boys with Duchenne muscular dystrophy after nosebleeds and dilated blood vessels showed up.⁸ So what do you do? Absolutely nothing. Unless you have a family member with SMA, this drug is not remotely in anyone's wheelhouse right now. It is prescription only, given by IV infusion, and the company puts the list price at about $310,000 a year for a typical patient.⁹ I am telling you this because it is yet another forward move in the medical world, and it is undoubtedly going to send the interwebs bananas about "unfettered" muscle growth. That is, in fact, not true, but the science snowball is rolling on. My job is to give you the honest information, and the above is that. Worth Remembering"She was beginning to know me and love me, and smiled when I went near. When I sang to her in my ridiculous voice, she liked to listen. She did not cry or frown when I kissed her; she stopped crying when I went to her. And now people say to comfort me that I shall have other children. But where is Sonya? Where is that little person for whom, I am bold enough to say, I would accept crucifixion if it meant she would live?"
— Fyodor Dostoevsky, in a letter to Apollon Maikov after the death of his three-month-old daughter, May 1868
I know this is a grim quote. Painful, even. Losing a child must be a suffering beyond measure. I am not sharing it to bring gloom to your Saturday morning. I am sharing it as a reminder not to let the moments slip by. Sing in your ridiculous voice. Roll around on the floor with your kids. Make the phone call. Put down your phone. The work can probably wait. I pray all of us get a full life with the people we love. But I know what it is to lose someone too soon, and I am grateful for the memories I have. Try This WeekI'm helping a client lose weight right now. Like most men in his spot, he has three options:
Training plus one of the first two always comes first. I'd be lying, though, if I said some men don't benefit from a GLP-1 right away. This week, try option 2:
Stick to it, and the scale will move. From the BookshelfThe Ronin Saga by Matthew Wolf As a good buddy of mine has told me many times, "Not every good book has a good cover, but all good covers enclose a good book." This one has a man facing down a dragon on the cover. Dragons are awesome. So far there are fewer dragons than I expected, but it is solid. It is worth the read if you are a fantasy nerd like me. If not, well, you can skip this section. Closing ThoughtWhen I was in middle school, Coach Eric ran our football team. He had plenty of clichés, but one stuck with me and has held true to this day: "You are the average of your five closest friends." Hundreds of men and plenty of mentors have repeated that line since. It is still the truth. I love the men's groups I work with. Some are three men, some are fifteen, and every one of them exists to make the others better. They compete, they talk trash, and they never stop pulling one another up. Few things are more beautiful than a community of good men helping each other become better men, husbands, and fathers. If you don't have a group like that, go find one. Join a men's club or a Bible study. Take up golf so other men can make fun of your swing. It doesn't matter where. Find a way
|
I'm an author, strength coach, and physical therapist — also a father, husband, and hack golfer. Every Saturday I send The Saturday Standard: research worth knowing, a thought worth keeping, an action worth taking, a book worth reading, and a note from me. Five things, five minutes, one coffee. This and other blog posts are available for free every week — join below.
The Saturday Standard — Vol. 24 Saturday, October 17, 2026 As always, coffee first, fellas — and let's talk about cramps, and why a few bananas and a gallon jug of water probably isn't the fix. The Research Cramps aren't a water problem You've been told your whole life that a cramp means you didn't drink enough water. Maybe you needed more salt. Maybe a banana. Electrolyte companies claim their fancy packets can fix your cramps. It makes sense on paper. You sweat, you lose water and sodium,...
The Saturday Standard — Vol. 22 Saturday, October 3, 2026 As always, coffee first, fellas — and let's sort out this whole "seed oils are the DEVIL" situation. The Research Seed oils are taking too much of the blame Seed oils are getting a lot of blame. But is it deserved? The internet treats them like villains in a Marvel movie, branding them the Hateful Eight and treating them as equal conspirators in destroying the world. The eight: canola, corn, cottonseed, soybean, sunflower, safflower,...
The Saturday Standard — Vol. 21 Saturday, September 26, 2026 As always, coffee first, fellas — and let's talk about testosterone, who actually needs it, and why some men are on it without ever being properly tested. The Research Should you be on TRT? Testosterone and men's wellness clinics are riding a high right now. From the Hims commercials about libido, weight loss, hair loss and the like, to local shops leaving flyers on your car, to your buddy at the gym who swears by this clinic up the...